Since being founded in 1992, the Cognitive Clinical Trials group has grown to become one of Canada's largest sites for conducting clinical research and drug trials related to dementia and Alzheimer's disease. Led by Dr. Michael Borrie, the group consists of Geriatricians,

Cognitive Neurologists, a Cognitive Neuropsychologist and clinical research coordinators. Some of the group's research capabilities include MRI (1.5T, 3.0T, 7.0T, FMRI, MR Spectroscopy), PET, CT, Lumbar Puncture, Cyclotron, and IV/SQ therapies.